Update 27 November 2018:
This medicine is back in stock.
Update 25 October 2018:
The Department of Health & Social Care (DHSC) have sent an alert and guidance to all healthcare professionals who prescribe, dispense or administer Epanutin 30mg/5ml Oral Suspension.
They have asked GPs to make early contact with their patients who are prescribed this medicine, to find out if they have enough supplies to last them until early December. If you don’t have enough supplies, you should make contact with your GP now, rather than wait to hear from them.
The DHSC says that your GP should seek advice from an epilepsy specialist on switching you to an alternative product. This alternative product may be another version of the oral suspension. If you take another version, you will need to be closely monitored as there can be a number of differences between versions. This monitoring may involve doing blood tests before you take the different version and one week after you start to take it.
Any switching to an alternative formulation for those under the age of 18 years should only be under the direct care of their specialist prescriber.
Original story: Pfizer, the makers of the epilepsy medicine Epanutin, have informed us that there is likely to be a shortage of Epanutin (phenytoin) 30mg/5ml Oral Suspension. They anticipate that it will be out of stock between 29 October and early December 2018. If you take Epanutin 30mg/50ml Oral Suspension, we would advise you talk to your healthcare professional. This is in case any changes need to be made to your treatment if you are unable to get a supply.
Pfizer tell us that they are looking at all options to see if there is a way to reduce the gap. We will keep you informed as and when we receive further information.